1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Janux Therapeutics, Inc.

Janux Therapeutics, Inc.

JANX
Janux Therapeutics, Inc.US flagNASDAQ Global Market
13.59
USD
-0.19
- -
828.78MMarket Cap

Income Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
4
9
8
11
10
+ Sales & Services Revenue
- -
- -
4
9
8
11
10
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-4
-9
-8
-11
-10
- Operating Expenses
4
5
37
76
81
109
168
+ Selling, General & Admin
1
2
10
22
26
41
42
+ Research & Development
3
3
26
53
55
68
126
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-4
-5
-33
-67
-73
-99
-158
- Non-Operating (Income) Loss
- -
2
- -
-4
-15
-30
-44
+ Interest Expense, Net
- -
- -
- -
-4
-15
-30
-44
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
4
15
30
44
+ Other Non-Op (Income) Loss
- -
2
- -
- -
- -
- -
- -
Pretax Income
-4
-7
-33
-63
-58
-69
-114
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-4
-7
-33
-63
-58
-69
-114
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-4
-7
-33
-63
-58
-69
-114
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-4
-7
-33
-63
-58
-69
-114
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-4
-7
-33
-63
-58
-69
-114
EBIT
-4
-5
-33
-67
-73
-99
-158
EBITDA
-4
-5
-33
-66
-71
-97
-156
EBITDA Margin (%)
- -
- -
-902.28
-769.28
-878.68
-914.12
-1,556.38
EBITA
-4
-5
-33
-67
-73
-99
-158
Gross Margin (%)
- -
- -
100
100
100
100
100
Operating Margin (%)
- -
- -
-905.39
-779.04
-902.87
-933.58
-1,576.67
Profit Margin (%)
- -
- -
-898.32
-732.22
-721.18
-651.62
-1,136.25
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
2
2
2
Basic Weighted Avg Shares
6
12
24
41
44
54
- -
Basic EPS, GAAP
-0.62
-0.54
-1.39
-1.52
-1.32
-1.28
- -
Basic EPS from Cont Ops
-0.62
-0.54
-1.39
-1.52
-1.32
-1.28
- -
Diluted Weighted Avg Shares
6
12
24
41
44
54
- -
Diluted EPS, GAAP
-0.62
-0.54
-1.39
-1.52
-1.32
-1.28
- -
Diluted EPS from Cont Ops
-0.62
-0.54
-1.39
-1.52
-1.32
-1.28
- -

Balance Sheet (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
1
16
377
332
349
1,034
976
+ Cash, Cash Equivalents & STI
1
8
375
327
344
1,025
967
+ Cash & Cash Equivalents
1
8
36
51
19
431
52
+ ST Investments
- -
- -
339
276
325
595
914
+ Accounts & Notes Receiv
- -
8
- -
- -
2
5
6
+ Accounts Receivable, Net
- -
8
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
2
5
6
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
2
5
3
3
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
3
32
31
28
26
+ Property, Plant & Equip, Net
- -
- -
2
29
28
24
22
+ Property, Plant & Equip
- -
- -
2
30
31
29
29
- Accumulated Depreciation
- -
- -
- -
1
3
5
7
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
2
3
4
3
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
2
3
4
3
Total Assets
1
16
380
364
380
1,062
1,002
+ Payables & Accruals
1
1
5
8
7
11
18
+ Accounts Payable
- -
- -
2
2
2
4
5
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
3
6
4
7
13
+ ST Debt
4
- -
- -
1
2
2
2
+ ST Borrowings
4
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
1
2
2
2
+ Other ST Liabilities
- -
2
8
8
5
5
5
+ Deferred Revenue
- -
2
5
5
2
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
2
3
3
5
5
Total Current Liabilities
5
3
13
17
13
17
25
+ LT Debt
- -
- -
- -
25
23
21
20
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
25
23
21
20
+ Other LT Liabilities
4
28
1
2
- -
- -
- -
+ Accrued Liabilities
- -
6
1
2
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
4
22
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
4
28
1
27
23
21
20
Total Liabilities
9
31
13
43
36
39
45
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
414
433
512
1,258
1,304
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
414
433
512
1,258
1,304
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-8
-15
-47
-110
-169
-238
-351
+ Other Equity
- -
- -
- -
-2
1
2
4
Equity Before Minority Interest
-8
-15
366
321
344
1,023
957
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-8
-15
366
321
344
1,023
957
Total Liabilities & Equity
1
16
380
364
380
1,062
1,002
Shares Outstanding
40
40
41
42
46
59
60
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
25
25
23
22
Net Debt
3
-8
-36
-51
-19
-431
-52
Net Debt to Equity
-42.07
53.37
-9.71
-16.03
-5.58
-42.1
-5.47
Tangible Common Equity Ratio
-1,169.96
-90.26
96.45
88.11
90.52
96.35
95.53
Current Ratio
0.14
5.05
29.46
20.14
26.8
59.21
39.04
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-4
-7
-33
-63
-58
-69
-114
+ Depreciation & Amortization
- -
- -
- -
1
2
2
2
+ Non-Cash Items
- -
2
7
15
12
22
23
+ Stock-Based Compensation
- -
- -
7
17
20
33
40
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
2
- -
-2
-8
-11
-18
+ Chg in Non-Cash Work Cap
- -
- -
9
4
-7
1
7
+ (Inc) Dec in Accts Receiv
- -
-8
8
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-2
-3
- -
-3
-1
+ Inc (Dec) in Accts Payable
- -
1
5
4
- -
6
7
+ Inc (Dec) in Other
- -
8
-3
4
-6
-2
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-4
-4
-17
-43
-51
-44
-82
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
-6
-2
- -
-1
+ Acq of Fixed Prod Assets
- -
- -
-1
-6
-2
- -
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
204
- -
57
698
- -
+ Increase in Capital Stock
- -
- -
204
- -
57
698
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-339
65
-39
-258
-300
+ Dec in LT Investment
- -
- -
134
359
278
213
405
+ Inc in LT Investment
- -
- -
-474
-294
-317
-471
-705
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-341
58
-41
-258
-301
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
4
2
- -
- -
- -
- -
- -
+ Cash From Debt
4
2
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
9
182
- -
3
15
5
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
4
12
387
- -
60
713
5
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
7
29
16
-32
411
-378
EBITDA
-4
-5
-33
-66
-71
-97
-156
EBITDA Margin (%)
- -
- -
-902.28
-769.28
-878.68
-914.12
-1,556.38
Free Cash Flow
-4
-4
-18
-49
-52
-44
-83
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-2
-18
-49
-52
-44
-83
Free Cash Flow per Basic Share
-0.6
-0.35
-0.78
-1.19
-1.19
-0.82
- -
Price/Free Cash Flow
- -
- -
-29.96
-14.97
-9.69
-66.23
- -
Cash Flow to Net Income
0.96
0.64
0.52
0.68
0.87
0.64
0.72
Capital Expenditures
- -
- -
-1
-6
-2
- -
-1